Regeneron Pharmaceuticals, Inc. | Patient Daily

Regeneron Pharmaceuticals, Inc.

Press release submission | Jan 2, 2021

REGENERON: Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen

Press release submission | Jul 5, 2020

Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Ruth de Jauregui | May 7, 2017

Survey finds majority of rheumatoid arthritis patients living in pain

Trending

+ Pharmaceuticals

Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’

+ Pharmaceuticals

Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program

+ Pharmaceuticals

Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’

+ Pharmaceuticals

Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’